Complementation Tests
Complement System
Predicting Reaction Outcomes
Pulmonary Function Tests
Long-term Depression
What is Genetic Engineering?
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Feb 12, 2026

Functional Complementation Analysis FCA: A Laboratory Exercise Designed and Implemented to Supplement the Teaching of Biochemical Pathways
Published on: June 24, 2016
Štefan Blazina1, Maruša Debeljak2, Mitja Košnik3,4
1Department of Allergology, Rheumatology and Clinical Immunology, Children's Hospital Ljubljana, University Medical Centre Ljubljana, Ljubljana, Slovenia.
This study looked at how to diagnose and classify complement deficiencies in patients from the Slovenian primary immunodeficiency registry. Researchers confirmed complement deficiencies using genetic testing and functional studies. They found that complement levels below heterozygous carriers defined complete deficiency, while levels above homozygous carriers defined partial deficiency. Patients with partial deficiency had higher infection risks than previously known. The study also found that complement deficiencies are more common in Slovenia than in other countries. These findings suggest that complement deficiencies are underdiagnosed globally. The results support broader screening and vaccination strategies for both complete and partial deficiency cases.
Area of Science:
Background:
Complement deficiencies (CDs) are rare immune system disorders that increase infection risks. The Slovenian primary immunodeficiency (PID) registry shows a higher CD prevalence than global registries. Prior research has shown CDs are underdiagnosed globally. No prior work had resolved why CDs are more common in Slovenia. This gap motivated a study to clarify CD types and infection risks. Researchers aimed to distinguish complete from partial CD. They also wanted to evaluate infection patterns in these groups. The study focused on improving CD recognition and management.
Purpose Of The Study:
The study aimed to confirm CD diagnoses in Slovenian PID patients and classify them as complete or partial. Researchers wanted to assess infection risks specific to each CD type. They evaluated clinical features and genetic data from registry patients. The goal was to compare Slovenian CD rates to global averages. They also sought to determine if functional complement studies could predict infection risks. The study aimed to improve diagnostic accuracy for CDs. Researchers wanted to guide vaccination strategies based on CD severity. Their work aimed to highlight under-recognized CD cases worldwide.
Main Methods:
Researchers used genetic testing to confirm CD in patients with C2, C8 deficiency, or hereditary angioedema. They also used functional complement studies and component measurements for other CD types. Homozygous and heterozygous carriers were distinguished via genetic and functional data. Complement levels below heterozygous thresholds defined complete CD. Levels above homozygous thresholds indicated partial CD. Infection risks were evaluated separately for each CD type. Clinical data was collected from the Slovenian PID registry. Researchers compared CD prevalence in Slovenia to global data.
Main Results:
Genetic testing confirmed CD in 26% of Slovenian PID patients, much higher than global rates of 0.5–6%. Functional studies reliably distinguished homozygous and heterozygous carriers. Complete CD was defined by complement levels below heterozygous thresholds. Partial CD was defined by levels above homozygous thresholds. Patients with partial CD had higher infection risks than previously reported. Functional complement studies predicted infection risks accurately. These findings suggest CDs are underdiagnosed globally. Vaccination against encapsulated bacteria is recommended for both CD types.
Conclusions:
The study implies CDs are under-recognized worldwide, especially in Slovenia. Functional complement studies and genetic testing reliably classify CD types. Researchers suggest vaccination should not be limited to complete CD cases. Infection risks in partial CD are higher than previously known. The findings support broader CD screening and management strategies. Functional complement studies are valuable for predicting infection risks. These results highlight the need for improved CD recognition. The study emphasizes the importance of accurate CD classification for clinical care.
The study found that complement functional studies and genetic testing can reliably distinguish complete and partial complement deficiencies in patients.
Complete deficiency is defined by complement levels below heterozygous carriers, while partial deficiency is defined by levels above homozygous carriers.
Functional complement studies help distinguish between homozygous and heterozygous carriers, which is essential for accurate diagnosis and risk assessment.
Genetic testing confirmed complement deficiencies in patients with C2, C8 deficiency, or hereditary angioedema, supporting functional study results.
Patients with partial complement deficiency have higher infection risks than previously reported, according to the study findings.
The study suggests vaccination against encapsulated bacteria should be recommended for both complete and partial complement deficiency cases.